HeartSciences Statistics

Total Valuation

HeartSciences has a market cap or net worth of $6.37 million. The enterprise value is $6.84 million.

Market Cap	6.37M
Enterprise Value	6.84M

Important Dates

The last earnings date was Monday, March 16, 2026, after market close.

Earnings Date	Mar 16, 2026
Ex-Dividend Date	n/a

Share Statistics

HeartSciences has 3.19 million shares outstanding. The number of shares has increased by 152.81% in one year.

Current Share Class	3.19M
Shares Outstanding	3.19M
Shares Change (YoY)	+152.81%
Shares Change (QoQ)	+13.73%
Owned by Insiders (%)	3.58%
Owned by Institutions (%)	7.73%
Float	3.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	735.05
Forward PS	n/a
PB Ratio	2.40
P/TBV Ratio	11.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	789.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 1.46.

Current Ratio	1.19
Quick Ratio	0.80
Debt / Equity	1.46
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.05

Financial Efficiency

Return on equity (ROE) is -382.32% and return on invested capital (ROIC) is -86.30%.

Return on Equity (ROE)	-382.32%
Return on Assets (ROA)	-73.51%
Return on Invested Capital (ROIC)	-86.30%
Return on Capital Employed (ROCE)	-237.30%
Weighted Average Cost of Capital (WACC)	16.49%
Revenue Per Employee	$578
Profits Per Employee	-$565,687
Employee Count	15
Asset Turnover	0.00
Inventory Turnover	0.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.48% in the last 52 weeks. The beta is 2.45, so HeartSciences's price volatility has been higher than the market average.

Beta (5Y)	2.45
52-Week Price Change	-37.48%
50-Day Moving Average	2.43
200-Day Moving Average	3.04
Relative Strength Index (RSI)	36.66
Average Volume (20 Days)	26,342

Short Selling Information

The latest short interest is 28,778, so 0.90% of the outstanding shares have been sold short.

Short Interest	28,778
Short Previous Month	35,192
Short % of Shares Out	0.90%
Short % of Float	0.94%
Short Ratio (days to cover)	2.28

Income Statement

In the last 12 months, HeartSciences had revenue of $8,669 and -$8.49 million in losses. Loss per share was -$4.03.

Revenue	8,669
Gross Profit	5,021
Operating Income	-7.80M
Pretax Income	-8.49M
Net Income	-8.49M
EBITDA	-7.77M
EBIT	-7.80M
Loss Per Share	-$4.03

Full Income Statement

Balance Sheet

The company has $3.40 million in cash and $3.87 million in debt, giving a net cash position of -$470,096 or -$0.15 per share.

Cash & Cash Equivalents	3.40M
Total Debt	3.87M
Net Cash	-470,096
Net Cash Per Share	-$0.15
Equity (Book Value)	2.65M
Book Value Per Share	0.83
Working Capital	829,925

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.34 million and capital expenditures -$3,554, giving a free cash flow of -$7.34 million.

Operating Cash Flow	-7.34M
Capital Expenditures	-3,554
Depreciation & Amortization	28,546
Net Borrowing	2.30M
Free Cash Flow	-7.34M
FCF Per Share	-$2.31

Full Cash Flow Statement

Margins

Gross Margin	57.92%
Operating Margin	-89,939.57%
Pretax Margin	-97,880.97%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HeartSciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-152.81%
Shareholder Yield	-152.81%
Earnings Yield	-133.16%
FCF Yield	-115.26%

Analyst Forecast

The average price target for HeartSciences is $8.00, which is 300.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	300.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 17, 2024. It was a reverse split with a ratio of 1:100.

Last Split Date	May 17, 2024
Split Type	Reverse
Split Ratio	1:100

Scores

HeartSciences has an Altman Z-Score of -17.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.75
Piotroski F-Score	2